Teva Pharmaceutical Industries Limited Announces Appointment of Dr. Arie Belldegrun to Board of Directors

Published: Feb 11, 2013

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that Dr. Arie Belldegrun was appointed by the Board of Directors of Teva, at its meeting of February 5, 2013, to fill a vacancy on the Board effective immediately. Dr. Belldegrun's term of office will extend until Teva’s 2013 Annual Meeting of Shareholders.

Back to news